NO157102C - AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin. - Google Patents

AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.

Info

Publication number
NO157102C
NO157102C NO822510A NO822510A NO157102C NO 157102 C NO157102 C NO 157102C NO 822510 A NO822510 A NO 822510A NO 822510 A NO822510 A NO 822510A NO 157102 C NO157102 C NO 157102C
Authority
NO
Norway
Prior art keywords
morpholinoethylamino
phenylpyridazine
preparation
therapeutic active
analogical procedure
Prior art date
Application number
NO822510A
Other languages
English (en)
Norwegian (no)
Other versions
NO157102B (no
NO822510L (no
Inventor
Jean-Paul Kan
Kathleen Biziere
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO822510L publication Critical patent/NO822510L/no
Publication of NO157102B publication Critical patent/NO157102B/no
Publication of NO157102C publication Critical patent/NO157102C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO822510A 1981-08-07 1982-07-21 AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin. NO157102C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8115380A FR2510998B1 (fr) 1981-08-07 1981-08-07 Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent

Publications (3)

Publication Number Publication Date
NO822510L NO822510L (no) 1983-02-08
NO157102B NO157102B (no) 1987-10-12
NO157102C true NO157102C (no) 1988-01-20

Family

ID=9261294

Family Applications (2)

Application Number Title Priority Date Filing Date
NO822510A NO157102C (no) 1981-08-07 1982-07-21 AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.
NO822509A NO157861C (no) 1981-08-07 1982-07-21 Analogifremgangsmaate til fremstilling av aminopyridaziner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO822509A NO157861C (no) 1981-08-07 1982-07-21 Analogifremgangsmaate til fremstilling av aminopyridaziner.

Country Status (30)

Country Link
US (1) US4508720A (ko)
EP (2) EP0072726B1 (ko)
JP (2) JPS5877868A (ko)
KR (2) KR890001569B1 (ko)
AR (2) AR231637A1 (ko)
AT (2) ATE18216T1 (ko)
AU (2) AU548930B2 (ko)
CA (2) CA1174240A (ko)
CS (2) CS229940B2 (ko)
DD (2) DD202715A5 (ko)
DE (2) DE3262671D1 (ko)
DK (2) DK148795C (ko)
EG (2) EG15788A (ko)
ES (2) ES514795A0 (ko)
FI (2) FI72968C (ko)
FR (1) FR2510998B1 (ko)
GR (2) GR76429B (ko)
HU (2) HU190028B (ko)
IE (2) IE53387B1 (ko)
IL (2) IL66408A (ko)
MA (2) MA19560A1 (ko)
NO (2) NO157102C (ko)
NZ (2) NZ201520A (ko)
OA (2) OA07176A (ko)
PH (1) PH18545A (ko)
PL (2) PL137199B1 (ko)
PT (2) PT75350B (ko)
SU (2) SU1140685A3 (ko)
YU (2) YU172082A (ko)
ZA (2) ZA825513B (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action
US4628088A (en) * 1984-07-17 1986-12-09 Eli Lilly And Company Preparation of substituted pyridazines
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2654727B1 (fr) * 1989-11-17 1992-03-27 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
ATE420867T1 (de) * 2002-08-13 2009-01-15 Merck Sharp & Dohme Phenylpyridazin derivative als liganden für gaba- rezeptoren
WO2006050389A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds, compositions and methods
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
WO2007127375A2 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
RU2555969C1 (ru) * 2014-07-09 2015-07-10 Юлия Алексеевна Щепочкина Керамическая масса для изготовления облицовочной плитки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives

Also Published As

Publication number Publication date
PH18545A (en) 1985-08-09
FI822747L (fi) 1983-02-08
PL137199B1 (en) 1986-05-31
JPS5877868A (ja) 1983-05-11
PL237809A1 (en) 1983-02-28
AU548930B2 (en) 1986-01-09
FI822748A0 (fi) 1982-08-06
KR880001624B1 (ko) 1988-09-02
IL66409A (en) 1985-09-29
EP0072726A1 (fr) 1983-02-23
CA1179346A (en) 1984-12-11
FI72968C (fi) 1987-08-10
PL130647B1 (en) 1984-08-31
US4508720A (en) 1985-04-02
GR76430B (ko) 1984-08-10
HU189166B (en) 1986-06-30
IL66408A0 (en) 1982-11-30
IL66408A (en) 1985-12-31
OA07176A (fr) 1984-04-30
NO822509L (no) 1983-02-08
AU548931B2 (en) 1986-01-09
DE3262671D1 (en) 1985-04-25
ZA825513B (en) 1983-06-29
IE53387B1 (en) 1988-10-26
CS229941B2 (en) 1984-07-16
DK148795C (da) 1986-03-10
ES8305738A1 (es) 1983-04-16
ES514794A0 (es) 1983-04-16
DK148537B (da) 1985-07-29
CA1174240A (en) 1984-09-11
FR2510998B1 (fr) 1986-01-10
SU1138024A3 (ru) 1985-01-30
YU172082A (en) 1985-03-20
NZ201518A (en) 1985-04-30
ZA825512B (en) 1983-06-29
IE821778L (en) 1983-02-07
KR890001569B1 (ko) 1989-05-08
HU190028B (en) 1986-08-28
FI72969C (fi) 1987-08-10
DD202715A5 (de) 1983-09-28
JPH0459312B2 (ko) 1992-09-21
DK354482A (da) 1983-02-08
PT75351B (fr) 1984-08-01
NO157102B (no) 1987-10-12
NO157861B (no) 1988-02-22
NO822510L (no) 1983-02-08
AR231637A1 (es) 1985-01-31
PT75350A (fr) 1982-08-01
IE53388B1 (en) 1988-10-26
PT75351A (fr) 1982-08-01
NO157861C (no) 1988-06-01
JPS5877867A (ja) 1983-05-11
MA19560A1 (fr) 1983-04-01
NZ201520A (en) 1985-04-30
SU1140685A3 (ru) 1985-02-15
IL66409A0 (en) 1982-11-30
ATE18216T1 (de) 1986-03-15
FI72969B (fi) 1987-04-30
KR840001159A (ko) 1984-03-28
ES8305737A1 (es) 1983-04-16
PL237808A1 (en) 1983-02-28
MA19562A1 (fr) 1983-04-01
KR840001145A (ko) 1984-03-28
AU8655482A (en) 1983-02-10
IE821779L (en) 1983-02-07
DK148537C (da) 1986-01-13
AR231441A1 (es) 1984-11-30
DE3269383D1 (en) 1986-04-03
EG15788A (en) 1986-09-30
FR2510998A1 (fr) 1983-02-11
PT75350B (fr) 1984-08-01
OA07175A (fr) 1984-04-30
FI72968B (fi) 1987-04-30
DK148795B (da) 1985-09-30
DD202549A5 (de) 1983-09-21
EP0074863B1 (fr) 1986-02-26
ATE12227T1 (de) 1985-04-15
YU171882A (en) 1985-03-20
ES514795A0 (es) 1983-04-16
FI822748L (fi) 1983-02-08
CS229940B2 (en) 1984-07-16
DK354382A (da) 1983-02-08
FI822747A0 (fi) 1982-08-06
AU8655382A (en) 1983-02-10
EP0072726B1 (fr) 1985-03-20
GR76429B (ko) 1984-08-10
EG15747A (en) 1986-06-30
EP0074863A1 (fr) 1983-03-23

Similar Documents

Publication Publication Date Title
NO157102C (no) AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO156940C (no) AnlogifremgangsmŸte til fremstilling av terapeutisk aktive cis, endo-2-azabicyklo-(3.3.0)-oktan-3-karboksylsyrer.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO820583L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(indolyl-piperidino-alkyl)-benzimidazolon-derivater.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO157173C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-(hydroksy-fenyl)-indoler.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.
NO158343C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater.